Craneware PLC
LSE:CRW

Watchlist Manager
Craneware PLC Logo
Craneware PLC
LSE:CRW
Watchlist
Price: 1 398 GBX 2.49% Market Closed
Market Cap: £496.4m

Craneware PLC
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Craneware PLC
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Craneware PLC
LSE:CRW
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Renalytix PLC
LSE:RENX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cambridge Cognition Holdings PLC
LSE:COG
Research & Development
-£2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Feedback PLC
LSE:FDBK
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doctor Care Anywhere Group PLC
ASX:DOC
Research & Development
-£3.7m
CAGR 3-Years
20%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
P
Physitrack PLC
STO:PTRK
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Craneware PLC
Glance View

Market Cap
496.4m GBX
Industry
Health Care

Craneware PLC, a prominent player in the healthcare software industry, crafts its narrative in the pursuit of financial optimization for hospitals across the United States. Established in 1999, Craneware recognized that hospitals were grappling with intricate billing processes and revenue cycle inefficiencies. By focusing on developing comprehensive software solutions, Craneware has strategically positioned itself to help these institutions navigate the labyrinth of medical billing and coding. With its suite of services, including charge capture, pricing analytics, and cost management, Craneware aids hospitals in maximizing their revenue and ensuring compliance. This focus allows healthcare providers to transform data into actionable insights, which not only streamlines operations but also enhances fiscal performance. Revenue generation for Craneware comes primarily from its software sales and accompanying support services. The company employs a Software as a Service (SaaS) model, wherein clients subscribe to its offerings on a recurring basis, ensuring a steady inflow of income while fostering long-term business relationships. This model capitalizes on the growing demand for cloud-based solutions, providing clients with the flexibility and scalability required in a constantly evolving healthcare landscape. Craneware’s unique positioning at the intersection of healthcare and financial management means its growth is not just dependent on acquiring new clients, but also on deepening engagements with existing ones, providing upgrades and enhancements that serve the ever-changing needs of the healthcare industry.

CRW Intrinsic Value
1 307.64 GBX
Overvaluation 6%
Intrinsic Value
Price GBX1 398

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett